RT @MCR_AACR: Want to read more about RAS after the #AACR22 session MS.ET06.01? Check out the review, Current Advances and Trends in #KRAS…

Want to read more about RAS after the #AACR22 session MS.ET06.01? Check out the review, Current Advances and Trends in #KRAS Targeted Therapies for #ColorectalCancer by Michelle Yee Mun Teo and colleagues. https://t.co/IrPt7LMzcn @ucsiuniversity https://t

#ReviewArticle discussing the most recent scientific approaches and clinical trials targeting KRAS mutations directly or indirectly for the management of #ColorectalCancer. https://t.co/BYZo66qYha https://t.co/I3ahXbtjEn

RT @MCR_AACR: This #ReviewArticle discusses the most recent scientific approaches and clinical trials targeting KRAS mutations directly or…

This #ReviewArticle discusses the most recent scientific approaches and clinical trials targeting KRAS mutations directly or indirectly for the management of #ColorectalCancer. https://t.co/8Q8BtzY0VV https://t.co/IztUvpYyOS

#ReviewArticle discussing the most recent scientific approaches and clinical trials targeting KRAS mutations directly or indirectly for the management of #ColorectalCancer. https://t.co/cKJXC6g6b1 https://t.co/YxqBmJYVSU

New article: Current advances and trends in KRAS targeted therapies for colorectal cancer https://t.co/FG25hqWCJ3 #colorectalcancer #oncology https://t.co/6e1kXZuvhp